This latest article on BioPharmaLife discusses how even though clinical trials in the US are going through a rough patch the Indian pharma outsourced industry is expected to thrive due to the economic crisis.
With many companies pulling back on investments, drug-makers are turning to India for cheaper resources for manufacturing and research. By the year 2011, the US is expected to have outsourced 65% of all its clinical trials to India.
Search This Blog
Blog Archive
-
▼
2008
(97)
-
▼
November
(15)
- Clinical Trials Market Expected to Grow in India D...
- Parexel Completes Chinese Bridging Study
- CROs Under Fire
- CRO BioReliance Enters Tech-Development
- India's clinical trials not affected by the recession
- MarketWatch: Quintiles, SAS Announce Development o...
- Biotrial, Full-Service CRO and European Leader in ...
- Economic Crisis Presents an Opportunity for the In...
- Mayo Clinic Pulls Out of Clinical Services
- MarketWatch: EyeGate Pharma Enrolls First Dry Eye ...
- Outsourced Clinical Trials Going Through a Rough P...
- Kendle sees revenue increase
- Nurse dismissed for error in clinical trials
- Nigeria Opens Clinical Trial Center
- India, China, Latin America and CEE as Clinical Tr...
-
▼
November
(15)
No comments:
Post a Comment